These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A synthetic dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection. Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD; Fischer E Transplant Proc; 1996 Apr; 28(2):593-4. PubMed ID: 8623290 [No Abstract] [Full Text] [Related]
11. Attempts to prepare suitable complement regulatory molecules for clinical xenotransplantation. Miyagawa S; Matsunami K; Yoshitatsu M; Mikata S; Matsuda H; Shirakura R J Card Surg; 2001; 16(6):429-38. PubMed ID: 11925023 [No Abstract] [Full Text] [Related]
12. Profound pulmonary hypertension characteristic of pig lung rejection by human blood is mediated by xenoreactive antibody independent of complement. Pierson RN; Kaspar-König W; Tew DN; Young VK; Braidley PC; White DJ; Wallwork J Transplant Proc; 1995 Feb; 27(1):274. PubMed ID: 7879001 [No Abstract] [Full Text] [Related]
13. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor. Dalmasso AP; Platt JL Transplantation; 1993 Nov; 56(5):1171-6. PubMed ID: 8249120 [TBL] [Abstract][Full Text] [Related]
14. Ancient proteins and futuristic surgery: the role of complement in discordant xenograft rejection. Winkler M Transplant Proc; 2001; 33(7-8):3862-4. PubMed ID: 11750645 [No Abstract] [Full Text] [Related]
15. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin in the pig-to-human combination. Gautreau C; Cardoso J; Woimant G; Zhao Z; Chereau C; Cherruau B; Vandeginste N; Devillier P; Houssin D Transplant Proc; 1994 Jun; 26(3):1281. PubMed ID: 8029908 [No Abstract] [Full Text] [Related]